ANALYSIS: Denmark Eliminates Mother-to-Child HIV Transmission—What Europe Can Learn from This Medical Miracle

ANALYSIS: Denmark Eliminates Mother-to-Child HIV Transmission—What Europe Can Learn from This Medical Miracle
Credit: Adobe Stock

From the 1980s to the First Antiretroviral Drugs

To understand what Denmark has accomplished, we must look back at history. In the early years of the HIV/AIDS epidemic, mother-to-child transmission was a brutal and unavoidable reality. The tools did not exist. Knowledge was fragmented. Prejudice was rampant. HIV-positive women were sometimes discouraged from having children, and sometimes sterilized without their consent. The approach was based on restriction rather than protection. This paradigm began to shift in the 1990s with the discovery that zidovudine—the first antiretroviral drug—administered during pregnancy significantly reduced the risk of transmission. The ACTG 076 study, published in 1994, was a global turning point. For the first time, medicine offered a concrete weapon against vertical transmission. Denmark, like most Western countries, quickly incorporated this breakthrough into its obstetric protocols. But universal and systematic access to care, widespread screening of all pregnant women, and the immediate initiation of treatment for any HIV-positive woman as soon as her pregnancy was confirmed—all of this would take years to solidify into a well-established system.

The true global turning point came in the late 1990s with the advent of combination antiretroviral therapy, known as triple therapy. These new protocols transformed HIV from a death sentence into a manageable chronic condition for patients who had access to treatment. For HIV-positive pregnant women on effective treatment, the viral load could become undetectable, reducing the risk of transmission to a level close to zero. The concept of “undetectable = untransmittable”—scientifically validated by the PARTNER and HPTN 052 studies—would revolutionize the very perception of the disease and its transmissibility. The tools existed. What remained was to build the systems to deploy them universally, equitably, and without fail.

There is something deeply human about this journey: decades of research, failures, fresh starts, and small victories that build up until one day, someone announces that it’s over. That for this country, for these women, for these children, this particular threat no longer exists. It takes a long time. It’s a slow process. That’s exactly how progress works.

The Danish Model: A Healthcare System Built for Universal Coverage

Denmark did not achieve this feat in a vacuum. It achieved it because its universal healthcare system—funded by taxes and accessible to all residents—creates the structural conditions in which this kind of victory is possible. HIV testing is routinely offered to all pregnant women during their first prenatal visit. In practice, it is not optional, even though it remains technically voluntary. The Danish medical culture, combined with a high level of trust in healthcare institutions, means that this screening is widely accepted. As soon as a pregnant woman is identified as HIV-positive, she enters a coordinated care protocol that integrates infectious disease medicine, obstetrics, pediatrics, and psychosocial support. Antiretroviral treatment is immediately initiated or adjusted, with the goal of achieving an undetectable viral load before delivery. Decisions to deliver by cesarean section are made when necessary to further minimize the residual risk. Breastfeeding, which is a route of transmission, is discouraged, and safe alternatives are offered. This entire process—from screening to birth, through to follow-up care for the newborn—operates with a consistency and continuity that are by no means accidental.

Share this post

facebook icon twitter icon linkedin icon
Copied!